Lenox Wealth Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1K Hold
19
﹤0.01% 701
2021
Q4
$1K Hold
19
﹤0.01% 828
2021
Q3
$1K Hold
19
﹤0.01% 664
2021
Q2
$1K Sell
19
-59
-76% -$3.93K ﹤0.01% 664
2021
Q1
$5K Buy
78
+59
+311% +$3.85K ﹤0.01% 498
2020
Q4
$1K Hold
19
﹤0.01% 593
2020
Q3
$1K Hold
19
﹤0.01% 545
2020
Q2
$1K Sell
19
-68
-78% -$3.67K ﹤0.01% 550
2020
Q1
$4K Hold
87
﹤0.01% 448
2019
Q4
$5K Hold
87
﹤0.01% 477
2019
Q3
$4K Buy
87
+68
+358% +$3.42K ﹤0.01% 416
2019
Q2
$1K Buy
+19
New +$922 ﹤0.01% 380

Other funds holding EHC

Lenox Wealth Advisors's EHC Position: Q1 2022 in Review

Lenox Wealth Advisors held its Encompass Health (EHC) position steady in Q1 2022 at 19 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Lenox Wealth Advisors first reported a position in EHC in Q2 2019 and has held it in 12 quarters since. The position peaked at $5K in Q1 2021. 407 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Lenox Wealth Advisors held 19 shares of Encompass Health worth $1K as of Q1 2022.
  • Lenox Wealth Advisors left its Encompass Health share count unchanged in Q1 2022.
  • Encompass Health made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #701 holding.
  • Lenox Wealth Advisors first reported a position in Encompass Health in Q2 2019 and has held it in 12 quarters since.
  • Lenox Wealth Advisors's Encompass Health position peaked at $5K in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.